• Clozapine, Serum
  • Hepatitis B Virus (HBV) by Molecular Method, Qualitative
  • Influenza Virus Type A and B, Antibody
  • Chromogranin A
  • Cystatin C, Serum
  • Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • Bordetella pertussis Culture
  • Cyclic AMP, Urine
  • Primary Hyperoxaluria Gene Mutation Panel
  • Fluticasone 17-Beta-Carboxylic Acid, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.